Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medplus Health ServicesNSE:MEDPLUS +2.06%76 EV-to-EBIT is 23.38 as of Aug. 27, 2026, which is 56% below its 10-year median of 53.64. GuruFocus rates NSE:MEDPLUS with a GF Score™ of 76/100 and a GF Value™ of ₹970.93 (Modestly Undervalued). Among 480 Healthcare Providers & Services companies, Medplus Health Services ranks worse than 69.79% on this metric.
The historical rank and industry rank for Medplus Health Services's EV-to-EBIT or its related term are showing as below:
NSE:MEDPLUS'
s EV-to-EBIT Range Over the Past 10 Years
Min: 20.57 Med: 53.64 Max: 102.4
Current: 23.38
During the past 8 years, the highest EV-to-EBIT of Medplus Health Services was 102.40. The lowest was 20.57. And the median was 53.64.
NSE:MEDPLUS's EV-to-EBIT is ranked worse than 69.79% of 480
companies
in the Healthcare Providers & Services industry
Industry Median: 15.75
vs NSE:MEDPLUS: 23.38
Medplus Health Services (NSE:MEDPLUS) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Medplus Health Services's Enterprise Value for the quarter that ended in Jun. 2026 was ₹97,361 Mil.
Medplus Health Services's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹3,908 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medplus Health Services EV-to-EBIT Related Terms
Medplus Health Services EV-to-EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medplus Health Services EV-to-EBIT Competitor Comparison
For the Pharmaceutical Retailers subindustry, Medplus Health Services's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medplus Health Services EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Medplus Health Services's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Medplus Health Services's EV-to-EBIT falls into.
Medplus Health Services's current Enterprise Value is ₹91,383 Mil.
Medplus Health Services's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹3,908 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medplus Health Services (NSE:MEDPLUS) has a EV-to-EBIT of 23.38 as of Aug. 27, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Medplus Health Services and its competitors. This is 56% below median its historical median of 53.64. Over the past decade, Medplus Health Services' EV-to-EBIT has ranged from 20.57 to 102.40. According to the industry distribution chart, Medplus Health Services ranks #335 out of 480 companies in the Healthcare Providers & Services industry, placing it in the top 69.8%.
Is Medplus Health Services' EV-to-EBIT too high?
Medplus Health Services' current EV-to-EBIT of 23.38 is 56% below median its 10-year median of 53.64. Over the past 10 years, this metric has ranged from a low of 20.57 to a high of 102.40. The Healthcare Providers & Services industry median EV-to-EBIT is 15.75. Medplus Health Services' value of 23.38 is 48.4% above this industry median. Based on the distribution chart, Medplus Health Services ranks #335 out of 480 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Medplus Health Services has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medplus Health Services' EV-to-EBIT compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Medplus Health Services ranks #335 out of 480 companies for EV-to-EBIT. This places Medplus Health Services in the lower half of its industry. The industry median EV-to-EBIT is 15.75. Medplus Health Services' value of 23.38 is 48.4% above this benchmark. Historically, Medplus Health Services' own EV-to-EBIT has ranged from 20.57 to 102.40 over the past decade. While the company's 10-year median is 53.64 vs. the industry median of 15.75, Medplus Health Services has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.75, based on 480 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medplus Health Services's current EV-to-EBIT of 23.38 is 48.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Medplus Health Services and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medplus Health Services's current EV-to-EBIT is 23.38, which is 56% below median its own 10-year median of 53.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medplus Health Services stock overvalued right now?
Based on GuruFocus' analysis, Medplus Health Services (NSE:MEDPLUS) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹970.93, compared to a current price of ₹692.10 — trading 28.7% below its estimated fair value. The current EV-to-EBIT is 23.38, which is 56% below median its 10-year median of 53.64 and 48.4% above the Healthcare Providers & Services industry median of 15.75. Medplus Health Services' overall GF Score™ is 76/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Medplus Health Services (NSE:MEDPLUS), the current EV-to-EBIT is 23.38 as of Aug. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medplus Health Services (NSE:MEDPLUS) Overvalued in 2026?
Based on GuruFocus' analysis, Medplus Health Services stock appears to be undervalued.
The current stock price of ₹692.10 is trading 28.7% below its estimated GF Value™ of ₹970.93.
GuruFocus considers Medplus Health Services to be Modestly Undervalued.
Key valuation signals for NSE:MEDPLUS:
EV-to-EBIT: 23.38 (56% below median its 10-year median of 53.64)
GF Value™: ₹970.93 vs. price of ₹692.10 (28.7% below fair value)
Industry Position: 48.4% above the Healthcare Providers & Services median (#335 of 480)
No single metric tells the full story. See the NSE:MEDPLUS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medplus Health Services Ltd is a pharmacy retailer. It offers pharmaceutical and wellness products such as medicines, vitamins, medical devices, test kits, and others. The company also offers an omnichannel platform wherein customers can purchase products through stores, place orders over the telephone, online orders, and a Click and Pick facility. Its operating segments include Retail, Diagnostics, and Others.
76GF Score
Get the complete analysis for NSE:MEDPLUS
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:MEDPLUS has been successfully added to your 
